SIGA Technologies, Inc. (SIGA) Financials

SIGA Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2025 219.5 trillion 20.6 trillion
Sept. 30, 2025 231.6 million 28.1 million
June 30, 2025 235.3 million 26.0 million
March 31, 2025 247.1 million 30.9 million

SIGA Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -11.3 million 729318
Sept. 30, 2025 -10.1 million 774104
June 30, 2025 63.1 million 1.2 million
March 31, 2025 7.0 million 902280

SIGA Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2025 30.5 million
Sept. 30, 2025 -6.4 million
June 30, 2025 35.5 million
March 31, 2025 -408223

SIGA Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 155.0 trillion - 595169
Sept. 30, 2025 172.0 million - 582666
June 30, 2025 182.5 million - 570426
March 31, 2025 162.3 million - 558651

SIGA Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 71.6 million
Sept. 30, 2025 71.6 million
June 30, 2025 71.7 million
March 31, 2025 71.4 million

SIGA Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 272021 8.4 million 5.3 million -
Sept. 30, 2025 289576 7.1 million 4.8 million -
June 30, 2025 1 4.4 million 5.5 million -
March 31, 2025 24893 3.5 million 5.7 million -

SIGA Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 3.8 million 3.0 million
Sept. 30, 2025 2.6 million 1.0 million
June 30, 2025 81.1 million 25.6 million
March 31, 2025 7.0 million 157738

SIGA Revenue by Segment

Graph available only for paid members. Upgrade to see it.

SIGA

Price: $3.58

52 week price:
3.42
9.62

Dividend Yield: 32.00%

Payout Ratio: 103.45%

Earnings Per Share: 0.32 USD

P/E Ratio: 16.56

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 610800

Ebitda: -18.3 million

Market Capitalization: 269.0 million

Average Dividend Frequency: 2

Links: